Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $204B | +$1.53B | 203 | 3.56% | Increased |
|
| 2 |
BlackRock
New York
| $179B | +$3.84B | 205 | 3.63% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $90.9B | +$514M | 188 | 3.58% | Increased |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $45.5B | -$341M | 159 | 2.72% | Reduced |
|
| 5 |
Geode Capital Management
Boston,
Massachusetts
| $45.1B | +$923M | 221 | 3.49% | Increased |
|
| 6 |
Morgan Stanley
New York
| $38.6B | +$214M | 214 | 2.7% | Increased |
|
| 7 |
T. Rowe Price Associates
Baltimore,
Maryland
| $34.3B | -$2.11B | 125 | 3.96% | Reduced |
|
| 8 |
JP Morgan Chase
New York
| $34.3B | +$1.71B | 200 | 2.56% | Increased |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $29.7B | -$2.34B | 65 | 5.44% | Reduced |
|
| 10 |
Norges Bank
Oslo,
Norway
| $25.1B | +$648M | 78 | 3.29% | Increased |
|
| 11 |
Capital Research Global Investors
Los Angeles,
California
| $24.7B | +$861M | 20 | 5.08% | Increased |
|
| 12 |
Bank of New York Mellon
New York
| $23.8B | -$1.13B | 144 | 4.4% | Reduced |
|
| 13 |
Northern Trust
Chicago,
Illinois
| $23B | +$2.83B | 189 | 3.26% | Increased |
|
| 14 |
Invesco
Atlanta,
Georgia
| $20.8B | +$984M | 123 | 3.85% | Increased |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $19.6B | -$2.13B | 226 | 1.64% | Reduced |
|
| 16 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $19.2B | +$2.61B | 32 | 11.86% | Increased |
|
| 17 |
Massachusetts Financial Services
Boston,
Massachusetts
| $18B | -$1.75B | 46 | 5.69% | Reduced |
|
| 18 |
Franklin Resources
San Mateo,
California
| $16.4B | -$324M | 107 | 4.56% | Reduced |
|
| 19 |
UBS AM
Chicago,
Illinois
| $15.9B | +$1.29B | 100 | 3.71% | Increased |
|
| 20 |
Charles Schwab
San Francisco,
California
| $14.5B | +$414M | 141 | 2.66% | Increased |
|
| 21 |
Goldman Sachs
New York
| $13.3B | -$646M | 160 | 2.1% | Reduced |
|
| 22 |
Dimensional Fund Advisors
Austin,
Texas
| $13.3B | +$655M | 128 | 3.19% | Increased |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $13.3B | +$218M | 10 | 2.49% | Increased |
|
| 24 |
Legal & General Group
London,
United Kingdom
| $13.2B | -$353M | 130 | 3.49% | Reduced |
|
| 25 |
Nuveen
Charlotte,
North Carolina
| $11.8B | -$471M | 130 | 3.34% | Reduced |
|